Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage, Aulos, Bicara, Biogen, Biontech, Black, Blossomhill, Boehringer, Denali, Eli Lilly, Fulgent, Immuneering, Inovio, Kelun-Biotech, Nuvalent, Olema, OSE, Regeneron, Remix, Rgenta, Sapience, Storm, SOBI, Zentalis.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adagio, Bayer, Hutchmed, Innovent, Junshi, Leo Cancer, Maat, Mabwell.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Ampersand, Biocardia, Carisma, Genethon, Gilead, Grundium, Hanmi, Implantica, Organon, Tubulis, United Immunity, Visiopharm.

Clinical updates for biopharma and med tech, including data readouts and publications: Apyx, Biomarin, Eli Lilly, Immix, Infex, Jupiter, Mink, Palvella, Palvella, Prolocor, Recode, Reflow.

Biopharma and med-tech companies raising money in public or private financings, including: Aim Immunotech, Akari, Immix, Jupiter, Relay, Theralase.

New hires and promotions in the biopharma and med-tech industries, including: Antag, Corbus, Immorta, Livanova, Neurophet, Ray, Realize, Theromics.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Diasorin, Guardant, Immunitybio, Implantica.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Discovery Life Sciences, Eli Lilly, Engage, Eton, Jupiter, Knight, Medtronic, Pharmala, SPR.